Atazanavir
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Laurus Labs Limited
EVOTAZ
atazanavir and cobicistat
Listed by E.R. Squibb & Sons, L.L.C.
- Strength
- 300 mg/1, 150 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Cytochrome P450 3A Inhibitor; Protease Inhibi…
What it contains
- Atazanavir Sulfate 300 mg/1
- Cobicistat 150 mg/1
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Cytochrome P450 3A Inhibitor; Protease Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0003-3641 |
| FDA application | NDA206353 |
| RxNorm concept | 1601654 |
| Package sizes listed | 1 |
| Marketed since | January 2015 |
Other products containing Atazanavir
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Atazanavir
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Camber Pharmaceuticals, Inc.
Atazanavir
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Laurus Labs Limited
Atazanavir
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Laurus Labs Limited
Atazanavir Sulfate
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Teva Pharmaceuticals USA, Inc.
Atazanavir Sulfate
Atazanavir
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Protease Inhibitor
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.